تخطَّ إلى المحتوى
دليل الأدوية المصري
تابع آخر تحديثات الأسعار على واتساب

دواعي استعمال تيتراسبان

  • Treatment of hypovolaemia due to acute blood loss when crystalloids alone are not considered sufficient.الفئة: AdultsFAGG-AFMPS (Belgian Federal Agency for Medicines and Health Products)
  • Treatment of hypovolaemia due to acute blood loss when crystalloids alone are not considered sufficient.Population: AdultsFAGG-AFMPS (Belgian Federal Agency for Medicines and Health Products)

معلومات الدواء

التفاصيل الكاملة
عن الدواءAbout the medicine

Hydroxyethyl starch (HES 130/0.42) 6% balanced electrolyte solution for intravenous infusion, 500 ml.

Hydroxyethyl starch (HES 130/0.42) 6% balanced electrolyte solution for intravenous infusion, 500 ml.

موانع الاستعمالContraindications
  • Contraindicated in sepsis, burns, renal impairment or renal replacement therapy, intracranial/cerebral haemorrhage, critically ill (ICU) patients, hyperhydration, pulmonary oedema, dehydration, hyperkalaemia, severe hypernatraemia/hyperchloraemia, severe hepatic impairment, congestive heart failure, severe coagulopathy, organ transplant patients, and hypersensitivity.نشرة دولية لنفس المنتج · FAGG-AFMPS (Belgian Federal Agency for Medicines and Health Products)
  • Contraindicated in sepsis, burns, renal impairment or renal replacement therapy, intracranial/cerebral haemorrhage, critically ill (ICU) patients, hyperhydration, pulmonary oedema, dehydration, hyperkalaemia, severe hypernatraemia/hyperchloraemia, severe hepatic impairment, congestive heart failure, severe coagulopathy, organ transplant patients, and hypersensitivity.International label, same product · FAGG-AFMPS (Belgian Federal Agency for Medicines and Health Products)
تحذيرات واحتياطاتWarnings & precautions
  • Risk of anaphylactic/anaphylactoid reactions: monitor closely and start infusion slowly.نشرة دولية لنفس المنتج · FAGG-AFMPS (Belgian Federal Agency for Medicines and Health Products)
  • Avoid volume overload; monitor serum electrolytes, fluid balance and renal function; stop HES at the first sign of renal injury.نشرة دولية لنفس المنتج · FAGG-AFMPS (Belgian Federal Agency for Medicines and Health Products)
  • Transient increase in serum alpha-amylase may occur and should not be interpreted as pancreatitis.نشرة دولية لنفس المنتج · FAGG-AFMPS (Belgian Federal Agency for Medicines and Health Products)
  • Risk of anaphylactic/anaphylactoid reactions: monitor closely and start infusion slowly.International label, same product · FAGG-AFMPS (Belgian Federal Agency for Medicines and Health Products)
  • Avoid volume overload; monitor serum electrolytes, fluid balance and renal function; stop HES at the first sign of renal injury.International label, same product · FAGG-AFMPS (Belgian Federal Agency for Medicines and Health Products)
  • Transient increase in serum alpha-amylase may occur and should not be interpreted as pancreatitis.International label, same product · FAGG-AFMPS (Belgian Federal Agency for Medicines and Health Products)
التداخلات الدوائيةDrug interactions
  • AminoglycosidesNephrotoxic effects of aminoglycosides may be increased with HES.FAGG-AFMPS (Belgian Federal Agency for Medicines and Health Products)
  • AminoglycosidesNephrotoxic effects of aminoglycosides may be increased with HES.FAGG-AFMPS (Belgian Federal Agency for Medicines and Health Products)
الحمل والرضاعةPregnancy & breastfeeding
  • No or limited data in pregnant women; animal studies with similar products showed reproductive toxicity; HES-related anaphylactoid reactions may harm the fetus. Use in pregnancy only if benefit outweighs risk.نشرة دولية لنفس المنتج · FAGG-AFMPS (Belgian Federal Agency for Medicines and Health Products)
  • No or limited data in pregnant women; animal studies with similar products showed reproductive toxicity; HES-related anaphylactoid reactions may harm the fetus. Use in pregnancy only if benefit outweighs risk.International label, same product · FAGG-AFMPS (Belgian Federal Agency for Medicines and Health Products)

تابع أسعار الأدوية أول بأول

بننشر كل يوم أسعار أدوية اتغيرت والبدائل الأرخص

المصادر

تعليقات

لا توجد تعليقات بعد. كن أول من يشارك تجربته مع هذا الدواء.

أضف تعليقًا

0/60

لا يُنشر أبدًا؛ للتواصل فقط إن لزم.

0/1000

من 20 إلى 1000 حرف. بدون روابط.

التعليقات للمعلومات العامة ولا تُعد نصيحة طبية. لا تذكر بيانات شخصية.